NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
4.330
+0.190 (4.59%)
At close: Jun 8, 2026, 4:00 PM EDT
4.330
0.00 (-0.01%)
Pre-market: Jun 9, 2026, 5:35 AM EDT
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $156.73 million as of June 9, 2026. Its market cap has increased by 237.05% in one year.
Market Cap
156.73M
Enterprise Value
150.95M
1-Year Change
237.05%
Ranking
Category
Stock Price
$4.33
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has increased from $65.80M to $156.73M, an increase of 138.19%. That is a compound annual growth rate of 10.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 156.90M | 106.18% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 160.34M |
| ProQR Therapeutics | 158.04M |
| Tenaya Therapeutics | 158.00M |
| Turn Therapeutics | 157.28M |
| Acumen Pharmaceuticals | 155.29M |
| Korro Bio | 154.61M |
| Galectin Therapeutics | 153.45M |
| Oramed Pharmaceuticals | 151.84M |